Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001638599-17-000348
Filing Date
2017-04-05
Accepted
2017-04-05 16:39:46
Documents
1
Period of Report
2014-09-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc4_4653.html 4  
1 PRIMARY DOCUMENT doc4_4653.xml 4 5995
  Complete submission text file 0001638599-17-000348.txt   7532
Mailing Address C/O IBIOPHARMA, INC. 9 INNOVATION WAY SUITE 100 NEWARK DE 19711
Business Address
MCKEY JOHN D JR (Reporting) CIK: 0001120452 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35023 | Film No.: 17743044

Mailing Address 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711
Business Address 9 INNOVATION WAY, SUITE 100 NEWARK DE 19711 302 355-0650
iBio, Inc. (Issuer) CIK: 0001420720 (see all company filings)

EIN.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations